Skip to main content

Genoptix, Inc. Investor Investigation Questions Potential Unfairness Of Buyout Offer By Novartis

  • If you are a long term investor in Genoptix, Inc. (NASDAQ:GXDX) and currently hold those GXDX shares, and/or if you have any information relating the investigation, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

After Novartis announced that the Genoptix board of directors agreed to a buyout offer of $25 per share an investigation for investors of Genoptix, Inc. (NASDAQ:GXDX) over possible breaches of fiduciary duty was announced within hours. The investigation by a law firm concerns whether certain directors and officers at Genoptix, Inc. (NASDAQ:GXDX) will breach their fiduciary duties in t...



You must register (for free) or login to view the entire investigation.